|
Market Cap (3-Jul) $356,619,552 (530th) |
Close (30-Jun) $0.315 |
Volume (30-Jun) 2,012,212 |
Shortsold (19-Jun) 27,150,697 (1.86%) (138th) |
|
52w High $0.415 |
52w Low $0.223 |
P/E 7.50 |
EPS -0.03 |
IMM released this announcement to the ASX on 1 September 2021, 10:07. The announcement is marked as price sensitive, and is 3 page(s) in length and 264.68kb in size.
You can view all announcements from IMM and see how they appear on a price chart on the announcements page.
At the date of this announcement, IMM was 0.040% short sold according to ASIC data. It was ranked the 501st most shorted stock on the ASX. It is now ranked as the 138th most shorted stock on the ASX with 1.859% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from IMM | |
|---|---|
| Application for quotation of securities - IMM | 29 June 2023, 10:09 |
| US patent granted for Efti with PD-1 pathway inhibitor | 27 June 2023, 14:37 |
| Immutep completes underwritten retail entitlement offer | 27 June 2023, 8:16 |
| Recruitment of patients completed for Part B of TACTI-002 | 1 September 2021, 10:07 |
| Immutep's partner, EOC Pharma, expands efti trial pipeline | 31 August 2021, 8:46 |
| Appendix 4E & 2021 Full Year Statutory Accounts | 30 August 2021, 19:08 |
| Chinese patent granted for anti-LAG-3 antibody LAG525 | 27 August 2021, 8:04 |
You must be logged in to post a reply.
